NORTHERN TRUST CORP

Bank

Position in APRE — Aprea Therapeutics, Inc.

CIK 73124 CHICAGO, IL

Position in APRE

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$10,991

+$1,488 QoQ

Shares Held

13,705

+854.4% QoQ

Ownership

0.109%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#16

of 28 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. APRE ranks #416 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,486,478	$1,235,108,212
2	REGN	Regeneron Pharmaceuticals, Inc.	916,467	$571,453,829
3	ALNY	Alnylam Pharmaceuticals, Inc.	886,900	$266,983,504
4	RPRX	Royalty Pharma plc	4,718,859	$264,586,419
5	RVMD	Revolution Medicines, Inc.	1,117,110	$209,212,357
6	MRNA	Moderna, Inc.	2,985,329	$209,062,587
7	INCY	Incyte Corp	1,761,966	$199,736,460
8	CYTK	Cytokinetics Inc	1,647,345	$140,337,319

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,991	13,705	-52.3%	Shares	Defined	2026-08-13
2022-12-31	$9,503	28,710	0.0%	Shares	Defined	2023-02-13
2022-09-30	$18,661	28,710	0.0%	Shares	Defined	2022-11-14
2022-06-30	$21,532	28,710	-1.7%	Shares	Defined	2022-08-12
2022-03-31	$54,320	29,205	-16.4%	Shares	Defined	2022-05-13
2021-12-31	$100,311	34,952	-1.3%	Shares	Defined	2022-02-08
2021-09-30	$180,934	35,408	+8.8%	Shares	Defined	2021-11-15
2021-06-30	$158,746	32,530	-69.2%	Shares	Defined	2021-08-13
2021-03-31	$539,164	105,719	-6.8%	Shares	Defined	2021-05-12
2020-12-31	$558,044	113,424	-3.9%	Shares	Defined	2021-02-11
2020-09-30	$2,839,439	118,015	+6.4%	Shares	Defined	2020-11-16
2020-06-30	$4,299,343	110,865	+36.6%	Shares	Other	2020-08-14
2020-03-31	$2,821,990	81,185	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.